Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 65/100

Failure Rate

20.0%

1 terminated/withdrawn out of 5 trials

Success Rate

0.0%

-86.5% vs industry average

Late-Stage Pipeline

60%

3 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

Phase 4
2(50.0%)
Phase 2
1(25.0%)
Phase 3
1(25.0%)
4Total
Phase 4(2)
Phase 2(1)
Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT07220902Phase 3Not Yet Recruiting

Levetiracetam Compared to Magnesium Sulfate for Prevention of Eclamptic Seizure

Role: lead

NCT07023003Phase 4Recruiting

Postpartum Evaluation of Nifedipine and Enalapril for Hypertension

Role: lead

NCT05309460Phase 4Recruiting

Labetalol or Nifedipine for Control of Postpartum Hypertension: A Randomized Controlled Trial

Role: lead

NCT04638465Active Not Recruiting

De-Escalation Protocol Of HPV Mediated Oropharyngeal Squamous Cell Carcinoma

Role: lead

NCT04880603Phase 2Terminated

Utility of Restrata With Split-thickness Skin Graft to Reconstruct the Forearm Donor Site

Role: lead

All 5 trials loaded